STING1 and cancer: Subsequent STING activation in astrocytes leads to the secretion of TNF‐α and IFN‐α, which activate NF‐κB and STAT1 signaling in cancer cells, ultimately promoting the survival and growth of metastatic cancer cells in the brain.231